Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2012-05-23 01:21 2012-05-18 ATRC AtriCure, Inc. Drachman David J Director, Officer OPT+S $8.23 39,184 $322,610 458,425
2012-05-22 19:21 2012-05-21 MRIC ClearPoint Neuro, Inc. PIETRANGELO MICHAEL Director BUY $0.76 10,000 $7,569 58,263
2012-05-22 20:17 2012-05-18 SYK STRYKER CORP STRYKER RONDA E Director SELL $51.08 27,000 $1,379,039 13,957,682
2012-05-23 01:46 2012-05-18 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $10.46 14,198 $148,488 112,308
2012-05-21 19:48 2012-05-21 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.58 5,000 $7,875 12,896,137
2012-05-21 23:55 2012-05-17 HAE HAEMONETICS CORP GELBMAN RONALD G Director SELL $71.49 2,473 $176,795 11,386
2012-05-18 20:10 2012-05-18 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.62 5,000 $8,100 12,891,137
2012-05-18 17:40 2012-05-17 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.64 2,500 $4,089 12,886,137
2012-05-19 02:04 2012-05-16 SYK STRYKER CORP STRYKER RONDA E Director SELL $51.70 18,000 $930,663 13,984,682
2012-05-18 21:51 2012-05-17 UFPT UFP TECHNOLOGIES INC ROCK MITCHELL Officer SELL $16.97 1,036 $17,581 78,506
2012-05-19 02:07 2012-05-16 OSUR ORASURE TECHNOLOGIES INC SPAIR RONALD H Director, Officer SELL $11.65 87,200 $1,015,880 250,567
2012-05-19 02:05 2012-05-16 OSUR ORASURE TECHNOLOGIES INC Michels Douglas A Director, Officer OPT+S $12.08 47,782 $577,302 581,429
2012-05-19 02:04 2012-05-16 OSUR ORASURE TECHNOLOGIES INC KUNA MARK L Officer OPT+S $12.07 15,175 $183,102 50,072
2012-05-17 22:12 2012-05-16 ANGO Angiodynamics Inc. Richard Stark Officer SELL $12.42 2,080 $25,827 20,922
2012-05-17 20:32 2012-05-17 MELA STRATA Skin Sciences, Inc. Goddard John Geoffrey Director BUY $2.90 10,000 $29,032 10,000
2012-05-17 03:26 2012-05-14 RMD RESMED INC QUINN MICHAEL A Director OPT+S $33.28 24,000 $798,739 302,000
2012-05-16 22:39 2012-05-15 LMAT LEMAITRE VASCULAR INC LeMaitre George W Director, Officer, 10% owner BUY $5.46 2,000 $10,920 3,915,163
2012-05-15 22:11 2012-05-15 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.67 6,500 $10,855 12,883,637
2012-05-16 01:24 2012-04-12 ANGO Angiodynamics Inc. BUCCI VINCENT Director BUY $11.87 2,000 $23,735 33,846
2012-05-15 20:34 2012-05-14 SYK STRYKER CORP STRYKER RONDA E Director SELL $52.43 18,000 $943,717 14,002,682
2012-05-15 23:43 2012-05-11 UFPT UFP TECHNOLOGIES INC ROCK MITCHELL Officer SELL $17.00 1,098 $18,666 79,542
2012-05-14 21:57 2012-05-14 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.63 10,000 $16,300 12,877,137
2012-05-11 19:18 2012-05-11 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.68 10,000 $16,800 12,867,137
2012-05-11 22:28 2012-05-10 GBSX Marizyme Inc. ERNST MARKUS RAINER Officer BUY $0.00 30,000 $0 30,000
2012-05-12 00:05 2012-05-09 INFU InfuSystem Holdings, Inc Meson Capital Partners LLC Director BUY $2.25 1,066,000 $2,398,500 1,545,876
2012-05-11 21:59 2012-05-10 SYK STRYKER CORP STRYKER RONDA E Director SELL $53.50 18,000 $963,022 14,020,682
2012-05-11 23:13 2012-05-11 UFPT UFP TECHNOLOGIES INC LATAILLE RONALD J Officer SELL $16.50 10,000 $165,000 124,305
2012-05-12 00:04 2012-05-09 INFU InfuSystem Holdings, Inc WHITTERS JOSEPH E Director BUY $2.25 100,000 $225,000 100,000
2012-05-10 17:58 2012-05-10 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.50 10,000 $15,000 12,857,137
2012-05-11 04:17 2012-05-08 ATRC AtriCure, Inc. Drachman David J Director, Officer OPT+S $9.09 23,061 $209,643 405,106
2012-05-10 19:06 2012-05-07 UFPT UFP TECHNOLOGIES INC ROCK MITCHELL Officer SELL $17.16 1,210 $20,759 80,640
2012-05-09 23:13 2012-05-09 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.57 10,000 $15,700 12,847,137
2012-05-09 19:57 2012-05-08 ATRC AtriCure, Inc. Lucky James L Officer SELL $9.06 8,000 $72,446 48,265
2012-05-10 00:05 2012-05-07 HAE HAEMONETICS CORP MERRIMAN RONALD Director SELL $71.46 1,000 $71,456 5,145
2012-05-09 18:32 2012-05-07 SYK STRYKER CORP STRYKER RONDA E Director SELL $53.61 27,000 $1,447,543 14,038,682
2012-05-09 02:18 2012-05-04 HAE HAEMONETICS CORP Nighan Warren JR Officer OPT+S $70.97 3,507 $248,901 2,846
2012-05-09 03:04 2012-05-08 BONE Xtant Medical Holdings, Inc. WICKWIRE JON M. Director BUY $1.53 20,000 $30,600 105,509
2012-05-08 22:38 2012-05-08 BONE Xtant Medical Holdings, Inc. COOK GUY S Director, Officer, 10% owner BUY $1.48 10,000 $14,800 12,837,137
2012-05-09 02:19 2012-05-04 HAE HAEMONETICS CORP KROLL MARK W Director OPT+S $71.09 20,000 $1,421,762 3,145
2012-05-08 16:40 2012-05-04 MMM 3M CO SAUER BRAD T Officer OPT+S $88.51 17,333 $1,534,173 13,558
2012-05-08 17:17 2012-05-08 MELA STRATA Skin Sciences, Inc. Gulfo Joseph V Director, Officer BUY $3.88 10,000 $38,800 153,311
2012-05-07 21:58 2012-05-03 OFIX Orthofix Medical Inc. Lee Brad Officer OPT+S $40.45 20,617 $833,999 6,481
2012-05-07 23:07 2012-05-03 HAE HAEMONETICS CORP Gordon Mikael Officer OPT+S $71.50 8,000 $571,987 4,442
2012-05-07 18:49 2012-05-03 MMM 3M CO Woodworth John K Officer OPT+S $89.38 30,532 $2,728,877 14,662
2012-05-07 23:09 2012-05-03 HAE HAEMONETICS CORP HANLON SUSAN M Officer OPT+S $71.44 8,000 $571,520 7,445
2012-05-08 02:16 2012-05-03 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer SELL $9.95 5,000 $49,744 979,889
2012-05-05 03:47 2012-05-02 RMD RESMED INC Farrell Michael J. Officer OPT+S $34.71 30,000 $1,041,270 53,410
2012-05-04 20:27 2012-05-02 OFIX Orthofix Medical Inc. Lee Brad Officer OPT+S $40.69 14,811 $602,599 6,481
2012-05-05 03:42 2012-05-02 RMD RESMED INC Sandercock Brett Officer SELL $34.75 20,000 $695,000 52,969
2012-05-04 21:56 2012-05-03 SYK STRYKER CORP STRYKER RONDA E Director SELL $54.43 18,000 $979,812 14,065,682
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.